UNSPSC 51142530: Lisuride
Commodity
Code facts
- Part of
-
-
51000000
-
51140000
- 51142500
-
51140000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51142530
Definition
This classification denotes an antiparkinsonian agent with the molecular formula C20H26N4O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E0QN3D755O, chemically known as 3-(9,10-didehydro-6-methylergolin-8alpha-yl)-1,1-diethylurea but generally known as lisuride, which bears US NIH Compound Identifier 28864. European Medicines Agency schedules Lisuride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08535MIG.
Read the full definition
The term LISURIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25, No. 10 1971, List 11). World Health Organization schedules lisuride in its Anatomical Therapeutic Chemical (ATC) Classification. LISURIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lisuride under HS 29396900 and SITC 54146. As of Q4 2014, LISURIDE remains the US FDA Preferred Term for this commodity. Lisuride bears US NLM identifiers UMLS ID C0023863 and NCI Concept Code C82247.
SMILES: O=C(NC1CN(C2C(=C1)C1C3C(C2)C[NH]C3CCC1)C)N(CC)CC.
About UNSPSC 51142530
UNSPSC 51142530 Lisuride, a Commodity code, does not match the work actually being solicited under this code classification. The single recent state and local opportunity tagged to this code is Seminole County, Florida's IFB 60459723LAS for Naloxone and Safe Drug Deactivation Systems — products unrelated to Lisuride, a dopamine agonist pharmaceutical. The mismatch suggests either a data-entry error in the county's e-Procurement system or a miscoding at the source. The nominal scope of UNSPSC 51142530 (Lisuride) does not reflect genuine procurement activity in the recent state and local market.
Seminole County released the Naloxone and Safe Drug Deactivation Systems bid on June 30, 2026, with a response deadline of July 26, 2023. The procurement calls for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; vendors must absorb all shipping and delivery costs. The contract term is two years with an optional one-year renewal, evaluated on a fixed-fee basis. Bidders must certify drug-free workplace status, E-Verify compliance, and maintain workers' compensation and commercial general liability insurance. FEMA funding introduces federal compliance requirements including the Clean Air Act and Federal Water Pollution Control Act. No explicit set-aside designations for minority or disadvantaged enterprises are stated. The procurement shows no meaningful activity under the Lisuride code itself.
Quick answers
What is UNSPSC 51142530?
UNSPSC 51142530 is Lisuride, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51142530?
UNSPSC 51142530 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).
On GovTribe
See everything under UNSPSC 51142530
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code